Back to discover
Drug

Zirconium

Preclinical / discovery stage
ResearchEarly translational research
RxNorm1534771UNIIC6V6S92N3C
3
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Radiopaque Intestinal Cast of Sodium Zirconium Cyclosilicate on CT

Industry2026-08-21Kidney International

Evaluating the immunologically "cold" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4 + and CD8 + T cells in breast cancer mouse models.

Research2024-06-25Breast cancer research : BCR

Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.

Research2023-09-01Clinical cancer research : an official journal of the American Association for Cancer Research

First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting.

Research2019-10-04Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Zirconium
RxNorm CUI
1534771
UNII
C6V6S92N3C

Research activity

3 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20202024
Major research themes8
Breast Neoplasms1CD4-Positive T-Lymphocytes1CD8-Positive T-Lymphocytes1Esophageal Neoplasms1Immune Checkpoint Inhibitors1Positron-Emission Tomography1Radioisotopes1Stomach Neoplasms1
Journals, researchers & institutions
Top journals
  • Breast cancer research : BCR1
  • Clinical cancer research : an official journal of the American Association for Cancer Research1
  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine1
Leading researchers
  • Lewis JS2
  • Pandit-Taskar N2
  • Aivazian A1
  • Barker CA1
  • Behera D1
  • Bhanot U1
  • Biachi De Castria T1
  • Bojilova V1
Leading institutions
free-text, unnormalised
  • Memorial Sloan Kettering Cancer Center2
  • Weill Cornell Medical College2
  • Beckman Research Institute of the City of Hope1
  • Harold C. Simmons Comprehensive Cancer Center1
  • Marie-Josée & Henry R. Kravis Center for Molecular Oncology1
  • O'Neal Comprehensive Cancer Center1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Trastuzumab

Studied across 5 of the same disease areas as Zirconium in the shared literature.

5 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature